S Günzelmann

416 total citations
9 papers, 308 citations indexed

About

S Günzelmann is a scholar working on Hematology, Transplantation and Infectious Diseases. According to data from OpenAlex, S Günzelmann has authored 9 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 5 papers in Transplantation and 2 papers in Infectious Diseases. Recurrent topics in S Günzelmann's work include Hematopoietic Stem Cell Transplantation (7 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Antifungal resistance and susceptibility (2 papers). S Günzelmann is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Antifungal resistance and susceptibility (2 papers). S Günzelmann collaborates with scholars based in Germany. S Günzelmann's co-authors include M. Bischoff, D Kirsten, Nadežda Basara, A. A. Fauser, Eric J. Romer, AA Fauser, N Basara, M. G. Kiehl, Michael Kiehl and IW Blau and has published in prestigious journals such as Clinical Infectious Diseases, Bone Marrow Transplantation and Clinical Transplantation.

In The Last Decade

S Günzelmann

9 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Günzelmann Germany 9 231 86 80 64 62 9 308
Olle Ringd n Sweden 8 183 0.8× 73 0.8× 40 0.5× 68 1.1× 148 2.4× 8 320
Sameh Ayari France 12 232 1.0× 71 0.8× 42 0.5× 144 2.3× 72 1.2× 23 345
Yuju Ohno Japan 10 254 1.1× 78 0.9× 13 0.2× 121 1.9× 106 1.7× 34 381
K B Lee South Korea 12 257 1.1× 145 1.7× 31 0.4× 126 2.0× 119 1.9× 13 409
D H Kim South Korea 10 235 1.0× 132 1.5× 29 0.4× 121 1.9× 118 1.9× 10 379
C. Arthur United Kingdom 8 270 1.2× 133 1.5× 10 0.1× 62 1.0× 70 1.1× 12 379
D-P Lu China 5 352 1.5× 170 2.0× 25 0.3× 118 1.8× 80 1.3× 7 425
Steven Lawrence Rosinski United States 6 215 0.9× 164 1.9× 16 0.2× 89 1.4× 82 1.3× 9 310
Gabriele Papalinetti Italy 9 243 1.1× 91 1.1× 19 0.2× 68 1.1× 25 0.4× 21 326
K Nakai Japan 9 215 0.9× 43 0.5× 11 0.1× 93 1.5× 100 1.6× 11 356

Countries citing papers authored by S Günzelmann

Since Specialization
Citations

This map shows the geographic impact of S Günzelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Günzelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Günzelmann more than expected).

Fields of papers citing papers by S Günzelmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Günzelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Günzelmann. The network helps show where S Günzelmann may publish in the future.

Co-authorship network of co-authors of S Günzelmann

This figure shows the co-authorship network connecting the top 25 collaborators of S Günzelmann. A scholar is included among the top collaborators of S Günzelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Günzelmann. S Günzelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Basara, Nadežda, M. G. Kiehl, Eric J. Romer, et al.. (2001). Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience. Transplantation Proceedings. 33(3). 2121–2123. 38 indexed citations
2.
Basara, Nadežda, S Günzelmann, Wolfgang Willenbacher, A. A. Fauser, & M. G. Kiehl. (2001). New immunosuppressants in BMT/GVHD. Transplantation Proceedings. 33(3). 2220–2222. 8 indexed citations
3.
Willenbacher, Wolfgang, et al.. (2001). Successful treatment of thrombocytopenia and hemolytic anemia with IvIG in a patient with lupus-like syndrome after mismatched related PBSCT. Bone Marrow Transplantation. 27(3). 337–340. 16 indexed citations
4.
Basara, Nadežda, Michael Kiehl, M. Bischoff, et al.. (2001). Toxoplasmosis, a Severe Complication in Allogeneic Hematopoietic Stem Cell Transplantation: Successful Treatment Strategies during a 5-Year Single-Center Experience. Clinical Infectious Diseases. 32(1). e1–e8. 49 indexed citations
5.
Blau, IW, N Basara, M. Bischoff, et al.. (2000). Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant. Bone Marrow Transplantation. 25(1). 41–45. 33 indexed citations
6.
Basara, N, et al.. (2000). Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA‐mismatched bone marrow transplant patients. Clinical Transplantation. 14(2). 121–126. 37 indexed citations
7.
Basara, Nadežda, IW Blau, M. Bischoff, et al.. (2000). Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study. Bone Marrow Transplantation. 25(4). 371–376. 16 indexed citations
8.
Basara, Nadežda, Eric J. Romer, M. Bischoff, et al.. (1998). Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients. Bone Marrow Transplantation. 22(1). 61–65. 81 indexed citations
9.
Basara, Nadežda, Michael Kiehl, Eric J. Romer, et al.. (1998). Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient. Transplantation Proceedings. 30(8). 4087–4089. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olle Ringd n Breakdown of academic impact, for papers by Sameh Ayari Breakdown of academic impact, for papers by Yuju Ohno Breakdown of academic impact, for papers by K B Lee Breakdown of academic impact, for papers by D H Kim Breakdown of academic impact, for papers by C. Arthur Breakdown of academic impact, for papers by D-P Lu Breakdown of academic impact, for papers by Steven Lawrence Rosinski Breakdown of academic impact, for papers by Gabriele Papalinetti Breakdown of academic impact, for papers by K Nakai
Rankless by CCL
2026